Tripterygium wilfordii Hook. f. and Xinfeng Capsule in Rheumatoid Arthritis: A Review of Clinical Evidence, Molecular Mechanisms, and Translational Perspectives - Scorecard - MDSpire
Advertisement
Tripterygium wilfordii Hook. f. and Xinfeng Capsule in Rheumatoid Arthritis: A Review of Clinical Evidence, Molecular Mechanisms, and Translational Perspectives
Clinical Scorecard: Efficacy and Mechanisms of Tripterygium wilfordii Hook. f. and Xinfeng Capsule in the Management of Rheumatoid Arthritis: A Comprehensive Review of Clinical Evidence and Translational Insights
At a Glance
Category
Detail
Condition
Key Mechanisms
Regulation of NF-κB and PI3K/AKT/mTOR pathways, ROS-NLRP3 inflammasome activation, synovial hyperplasia, angiogenesis, immune cell dysfunction.
Target Population
Care Setting
Key Highlights
TWHf-derived compounds improve disease activity and joint symptoms.
Xinfeng Capsule exhibits broader multi-component and multi-target regulation.
Clinical studies indicate efficacy when used alone or with specific DMARDs/biologics.
Challenges include toxicity and lack of high-quality multicenter RCTs.
Future studies should focus on standardized formulations and safety monitoring.
Guideline-Based Recommendations
Diagnosis
Include specific diagnostic criteria or guidelines.
Management
Consider TWHf-related preparations for improving disease activity and inflammatory markers.
Monitoring & Follow-up
Focus on safety monitoring and toxicity-attenuating delivery systems.
Risks
Toxicity and insufficient standardization of TWHf preparations.
Patient & Prescribing Data
TWHf and XFC may enhance efficacy and reduce toxicity via compound compatibility; consider potential interactions with other treatments.
Clinical Best Practices
Utilize biomarker-guided precision application of TWHf and XFC, specifying examples of biomarkers.
Conduct rigorous clinical evaluations of TWHf-related preparations.
